|
Volumn 35, Issue SUPPL. 1, 2002, Pages
|
Viral hepatitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
FAMCICLOVIR;
HEPATITIS A VACCINE;
HEPATITIS B VACCINE;
HEPATITIS C VACCINE;
INTERFERON;
RIBAVIRIN;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DISEASE COURSE;
DRUG EFFICACY;
ERADICATION THERAPY;
FOOD AND DRUG ADMINISTRATION;
GENOTYPE;
GEOGRAPHIC DISTRIBUTION;
GOVERNMENT;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH ECONOMICS;
HEPATITIS A;
HEPATITIS A VIRUS;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
IMMUNIZATION;
INFECTION CONTROL;
LIVER CARCINOGENESIS;
LIVER CELL CARCINOMA;
LIVER TRANSPLANTATION;
PATHOGENESIS;
PRIORITY JOURNAL;
REVIEW;
TREATMENT OUTCOME;
VACCINATION;
VIRUS HEPATITIS;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
CHILD;
ECONOMICS;
LIVER DISEASE;
LIVER TUMOR;
RESEARCH;
VIROLOGY;
CHILD;
HEPATITIS A;
HEPATITIS B;
HEPATITIS C;
HEPATITIS, VIRAL, HUMAN;
HUMAN;
LIVER DISEASES;
LIVER NEOPLASMS;
RESEARCH;
HUMANS;
|
EID: 0036065915
PISSN: 02772116
EISSN: None
Source Type: Journal
DOI: 10.1097/00005176-200207001-00008 Document Type: Review |
Times cited : (12)
|
References (16)
|